CTRI/2022/03/040851已完成未知
ASSESSMENT OF EARLY TREATMENT RESPONSE AND DOSIMETRIC EVALUATION IN LOCALLY ADVANCED CERVICAL CANCER TREATED WITH 3D CONFORMAL RADIATION THERAPY ALONG WITH CONCURRENT CISPLATIN AND IMAGE GUIDED HIGH DOSE RATE BRACHYTHERAPY
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- AIIMS
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Biopsy proven carcinoma of cervix 2. Age : between 18-65 yrs 3. FIGO Stage IIB â?? IIIB 4. Karnofsky performance scale score 70 or above 5. Normal kidney, liver and bone marrow function 6. Patient who have given informed consent
排除标准
- •1. Early stage cancer FIGO stage IA â??IIA 2. Metastatic patients 3. Lack of Histo-pathological proof of malignancy 4. Doubtful follow-up and /or non-compliance 5. Uncontrolled co-morbid conditions e.g. Hypertension, Diabetes Mellitus, Chronic Obstructive pulmonary disease (COPD), coronary artery disease (CAD), Severe Mental or Physical Disorder 6. Pregnancy 7. Deranged renal, liver function test 8. Patient refusing to give written informed consent 9. H/O- of previous irradiation 10. H/O-of allergy 11. Collagen vascular disease
研究者
相似试验
已完成
不适用
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecifiedDRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62
招募中
不适用
ERASE_Evaluation of early treatment response of soft tissue sarcomas under neoadjuvant hyperthermia and chemotherapy using functional MRI as well as FDG PET-CTC41.9C41Bone and articular cartilage, unspecifiedMalignant neoplasm of bone and articular cartilage of other and unspecified sitesDRKS00016070Klinikum der Universität München, Campus Großhadern35
进行中（未招募）
不适用
Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes - DEFEND 2MedDRA version: 12.1Level: LLTClassification code 10012608Term: Diabetes mellitus insulin-dependentType 1 Diabetes MellitusEUCTR2010-018775-17-ITTolerx, Inc.396
撤回
3 期
Durable-Response Therapy Evaluation For Early -or New-Onset Type 1 Diabetes.Type-1 Diabetes10003816NL-OMON34462Tolerx Inc.25
已完成
不适用
Early treatment effect and prognosis measurement of bone metastasis in prostate cancer patients by using whole-body diffusion-weighted imaging.prostate cancerJPRN-UMIN000035857Keio University60